Cognios Beta Neutral Large Cap Fund, LP Amgen Inc Transaction History
Cognios Beta Neutral Large Cap Fund, LP
- $74.5 Million
- Q1 2024
A detailed history of Cognios Beta Neutral Large Cap Fund, LP transactions in Amgen Inc stock. As of the latest transaction made, Cognios Beta Neutral Large Cap Fund, LP holds 1,936 shares of AMGN stock, worth $641,377. This represents 0.74% of its overall portfolio holdings.
Number of Shares
1,936
Previous 2,135
9.32%
Holding current value
$641,377
Previous $614,000
10.42%
% of portfolio
0.74%
Previous 0.83%
Shares
6 transactions
Others Institutions Holding AMGN
# of Institutions
2,959Shares Held
402MCall Options Held
6.59MPut Options Held
6.61M-
Vanguard Group Inc Valley Forge, PA52.1MShares$17.3 Billion0.3% of portfolio
-
Black Rock Inc. New York, NY48MShares$15.9 Billion0.32% of portfolio
-
State Street Corp Boston, MA29.1MShares$9.65 Billion0.38% of portfolio
-
Primecap Management CO Pasadena, CA14.6MShares$4.84 Billion3.15% of portfolio
-
Morgan Stanley New York, NY14MShares$4.63 Billion0.32% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $177B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...